A phase II trial of erlotinib (OSI-774) in patients (pts) with recurrent malignant gliomas (MG) not on EIAEDs Meeting Abstract


Authors: Raizer, J. J.; Abrey, L. E.; Wen, P.; Cloughesy, T.; Robins, I. A.; Fine, H. A.; Lieberman, F.; Puduvalli, V. K.; Fink, K. L.; Prados, M.
Abstract Title: A phase II trial of erlotinib (OSI-774) in patients (pts) with recurrent malignant gliomas (MG) not on EIAEDs
Meeting Title: 40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 22
Issue: 14 Suppl.
Meeting Dates: 2004 Jun 5-8
Meeting Location: New Orleans, LA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2004-07-15
Start Page: 107S
Language: English
ACCESSION: WOS:000223512400422
PROVIDER: wos
DOI: 10.1200/jco.2004.22.90140.1502
Notes: Meeting Abstract: 1502 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lauren E Abrey
    278 Abrey